New AI Tech To Improve AFib Treatment Slated For 2020 Market Launch

Marseille-based Volta Medical is targeting a 2020 release for its AI software to guide cardiologists through atrial fibrillation (AF) procedures. The start-up has recently published data demonstrating the potential of its technology.

A new AI software developed by French start-up Volta Medical for helping cardiologists treat atrial fibrillation (AF) more effectively could be commercially available within two years. The Marseille-based company told Medtech Insight that it is currently in talks to secure some Series A funding to advance development of AIFib, take it through more clinical studies and hopefully launch it in 2020.

AF is caused by a dysfunction in the atria that disrupts the mechanical contraction of the heart. The irregular heartbeats prevent the heart from pumping blood efficiently which can cause...

More from AI

More from Digital Technologies